BeStock  
Stocks › Biotechnology › ODTX

Odyssey Therapeutics ODTX

US equityMarket cap rank #3341Biotechnology
$18.08 −$0.05 (-0.28%)
Market closed · Oct 8, 4:10 am ET · Last extended-hours $18.08 0.00%
Open$18.01
Prev close$18.13
Day range$17.83 – $18.84
Volume264.1K
Market cap$868.90M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.4x
CheapRich

Near the top of its 5-year range · 82nd percentile, 5-year average -6.0x

Price / book2.1x
CheapRich

Above its usual level · 61st percentile, 5-year average 0.1x

#2985 of 5317 stocks by PB (1 = cheapest)

Price / sales8,776.7x
CheapRich

Above its usual level · 61st percentile, 5-year average 4,832.0x

#5120 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-9x-6x-3x1xMay '26Jul '26Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$26.79
Price vs. fair value-32.5%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.06 – 0.08 61% (pricier than usual) #2985 of 5317 (1 = cheapest)
PE -5.41 -4.10 -6.01 82% (pricier than usual) –
PS 8,776.75 – 4,832.02 61% (pricier than usual) #5120 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★
Fair value estimate$26.79
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on ODTX.

Leave a comment

Scroll to Top